Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
QSI
STRONG SELLQuantum-Si incorporated · Healthcare · United States · $168M · Avg Vol: $3M/d
COMPANY DESCRIPTION
Quantum-Si incorporated develops a next-generation protein sequencing platform, aiming to revolutionize proteomics research and drug discovery. Its proprietary semiconductor chip-based technology enables single-molecule protein sequencing, offering unprecedented insights into protein biology. This innovative approach positions Quantum-Si as a potential disruptor in the life sciences tools market, providing a distinct technological moat in an emerging high-growth area.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 1.1M | 3.1M | 2.4M | 50.0% | 1.9M | 1.0M | — | -57.6% |
| EPS | -0.95 | -0.68 | -0.71 | -0.51 | — | -0.50 | -0.40 | -0.36 | — |
| Shares | 139.9M | 141.8M | 166.9M | 216.4M | +54.6% | 197.8M | — | — | — |
| Debt | 17.4M | 15.3M | 12.9M | 4.2M | -38.0% | 3.7M | — | — | — |
| Equity | 358.7M | 271.6M | 215.4M | 220.2M | -15.0% | — | — | — | — |
| Op CF | -90.6M | -94.0M | -87.8M | -94.7M | — | -94.2M | — | — | — |
| Inv CF | 137.2M | 143.4M | -32.7M | -28.3M | — | — | — | — | — |
| Fin CF | 1.9M | 0.1M | 35.9M | 95.4M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of QSI are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| QSI | Quantum-Si incorporated(you) | $168M | 11 | STRONG SELL |
| OWLT | Owlet, Inc. | $153M | 11 | STRONG SELL |
| LUCD | Lucid Diagnostics Inc. | $173M | 7 | STRONG SELL |
| CVRX | CVRx, Inc. | $126M | 12 | STRONG SELL |
| QTRX | Quanterix Corporation | $173M | 20 | SELL |
| STIM | Neuronetics, Inc. | $120M | 16 | STRONG SELL |
| HYPR | Hyperfine, Inc. | $95M | 13 | STRONG SELL |
| TLSI | TriSalus Life Sciences, Inc. | $259M | 16 | STRONG SELL |
| SENS | Senseonics Holdings, Inc. | $254M | 4 | STRONG SELL |
| RXST | RxSight, Inc. | $215M | 23 | SELL |
Peer medians: ROE -25.5% · P/E 27.6x · Gross margin 50.6%